Cavan M. Redmond's Net Worth
$6.01 Million
Who is Cavan M. Redmond?
Cavan M. Redmond has an estimated net worth of $6.01 Million. This is based on reported shares across multiple companies, which include PFIZER INC, BIOTIME INC, Oncocyte Corp, WYETH, and WebMD Health Corp..
SEC CIK
Cavan M. Redmond's CIK is 0001420120
Past Insider Trading and Trends
2012 was Cavan M. Redmond's most active year for acquiring shares with 6 total transactions. Cavan M. Redmond's most active month to acquire stocks was the month of January. 2009 was Cavan M. Redmond's most active year for disposing of shares, totalling 16 transactions. Cavan M. Redmond's most active month to dispose stocks was the month of September. 2022 saw Cavan M. Redmond paying a total of $47,560.00 for 50,000 shares, this is the most they've acquired in one year. In 2009 Cavan M. Redmond cashed out on 339,873.966 shares for a total of $2,474,842.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PFIZER INC (PFE) Snapshot price: $27.525
Group President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| +16.32% | 21.21K |
—
|
—
| 151.14K |
Feb 23
| |||
Form 4
| +43.30% | 37.85K |
—
|
—
| 125.26K |
Feb 24
| |||
Form 4
| +35.90% | 22.28K |
—
|
—
| 84.35K |
Feb 25
| |||
Form 4
| +331.47% | 46.98K |
—
|
—
| 61.15K |
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOTIME INC (LCTX) Snapshot price: $1.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oncocyte Corp (OCX) Snapshot price: $2.9201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.02% | 10K |
—
|
—
| 120.86K |
Jun 24
| |||
Form 4
| +56.45% | 40K |
$1.19 | $47,560.00 | 110.86K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +35.11% | 18.42K |
—
|
—
| 70.86K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
∞
| 52.45K |
—
|
—
| 52.45K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
WYETH No price found
Pres., WCH & FDAH
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -67.28K |
$49.58 |
—
|
0
|
Oct 15
| |||
Form 4
| -3.09% | -1.15K |
$42.10 | -$48,288.70 | 35.92K |
Apr 27
| |||
Form 4
| +14.62% | 4.72K |
$41.14 | -$85,488.92 | 37.02K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
| -3.44% | -1.15K |
$44.93 | -$51,534.71 | 32.16K |
Apr 21
| |||
Form 4
| +13.86% | 4.05K |
$42.54 | -$75,933.90 | 33.3K |
Feb 29
| |||
Form 4
| +160.00% | 18K |
—
|
—
| 29.25K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
WebMD Health Corp. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |